[Helicobacter pylori and gastroduodenal pathology. Second part: Clinical aspects and therapy].
Sobhani
I
I
Service de Gastroentérologie, Hôpital Bichat, Paris.
Flourié
B
B
Lavergne
A
A
Colimon
R
R
Mignon
M
M
Modigliani
R
R
Rambaud
J C
JC
D000126:Achlorhydria / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000382:microbiology*; D004415:Dyspepsia / Q000382:microbiology; D005756:Gastritis / Q000188:drug therapy / Q000382:microbiology*; D016481:Helicobacter Infections / Q000188:drug therapy / Q000382:microbiology*; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D013276:Stomach Ulcer / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D001729:Bismuth
Helicobacter pylori et pathologie gastroduodénale. Seconde partie: Aspects cliniques et thérapeutiques.